Roy Beck, MD, PhD

Roy Beck, MD, PhD, is the founder of the Jaeb Center for Health Research.

Articles by Roy Beck, MD, PhD

INHALE-1: Afrezza Safe but Misses HbA1c Endpoint in Children With T1D or T2D, With Roy Beck, MD, PhD

April 19th 2026

Beck discusses the recently presented results of INHALE-1, in which technosphere insulin failed to prove noninferiority to RAA but had no pulmonary effects.

INHALE-3 Analysis Supports Need for Increased Technosphere Insulin Doses, With Roy Beck, MD, PhD

ByRoy Beck, MD, PhD

April 17th 2026

Beck discusses a recent analysis of the phase 4 trial comparing TI and degludec against standard treatment, highlighting the need for individualized titration.